Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Alnylam and Dicerna form RNAi Therapeutics collaboration on alpha-1 liver disease

pharmaceutical-business-reviewApril 09, 2020

Tag: Alnylam Pharmaceuticals , Dicerna Pharmaceuticals , alpha-1 liver disease , RNAi Therapeutics

PharmaSources Customer Service